BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 29557072)

  • 1. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
    Sonmez C; Yucel AA; Yesil TH; Kucuk H; Sezgin B; Mercan R; Yucel AE; Demirel GY
    Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
    Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
    Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Th-17 and RORγt mRNA in Behçet's Disease.
    Hamzaoui K; Bouali E; Ghorbel I; Khanfir M; Houman H; Hamzaoui A
    Med Sci Monit; 2011 Apr; 17(4):CR227-34. PubMed ID: 21455110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum IL-33 levels and skin mRNA expression in Behçet's disease.
    Hamzaoui K; Kaabachi W; Fazaa B; Zakraoui L; Mili-Boussen I; Haj-Sassi F
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):6-14. PubMed ID: 23464866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased serum interleukin-32 levels in patients with Behçet's disease.
    Ha YJ; Park JS; Kang MI; Lee SK; Park YB; Lee SW
    Int J Rheum Dis; 2018 Dec; 21(12):2167-2174. PubMed ID: 28378461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
    Na SY; Park MJ; Park S; Lee ES
    Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-26 is overexpressed in Behçet's disease and enhances Th17 related -cytokines.
    Kaabachi W; Bouali E; Berraïes A; Dhifallh IB; Hamdi B; Hamzaoui K; Hamzaoui A
    Immunol Lett; 2017 Oct; 190():177-184. PubMed ID: 28811236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disturbed Th17/Treg balance, cytokines, and miRNAs in peripheral blood of patients with Behcet's disease.
    Ahmadi M; Yousefi M; Abbaspour-Aghdam S; Dolati S; Aghebati-Maleki L; Eghbal-Fard S; Khabbazi A; Rostamzadeh D; Alipour S; Shabani M; Nouri M; Babaloo Z
    J Cell Physiol; 2019 Apr; 234(4):3985-3994. PubMed ID: 30317557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-6 (IL-6) in patients with Behçet's disease.
    Yamakawa Y; Sugita Y; Nagatani T; Takahashi S; Yamakawa T; Tanaka S; Nakamura S; Ohno S; Sekihara H; Okuda K; Nakajima H
    J Dermatol Sci; 1996 Mar; 11(3):189-95. PubMed ID: 8785169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-28A promotes IFN-γ production by peripheral blood mononuclear cells from patients with Behçet's disease.
    Li B; Xie C; Lin X; Su SB
    Cell Immunol; 2014 Jul; 290(1):116-9. PubMed ID: 24973639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Cytokine Levels in Behçet's Disease.
    Akkurt ZM; Bozkurt M; Uçmak D; Yüksel H; Uçak H; Sula B; Gürsel Özkurt Z; Yildiz M; Akdeniz D; Arica M
    J Clin Lab Anal; 2015 Jul; 29(4):317-20. PubMed ID: 25130392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D modulates peripheral immunity in patients with Behçet's disease.
    Hamzaoui K; Ben Dhifallah I; Karray E; Sassi FH; Hamzaoui A
    Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S50-7. PubMed ID: 20868571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of the profile of CD4+ cells in Behçet's disease].
    Sugi N; Nakazawa M; Nakamura S; Minami M; Ohno S
    Nippon Ganka Gakkai Zasshi; 1997 Apr; 101(4):335-40. PubMed ID: 9136573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum MMP-2 and MMP-9 in patients with Behçet's disease: do their higher levels correlate to vasculo-Behçet's disease associated with aneurysm formation?
    Pay S; Abbasov T; Erdem H; Musabak U; Simsek I; Pekel A; Akdogan A; Sengul A; Dinc A
    Clin Exp Rheumatol; 2007; 25(4 Suppl 45):S70-5. PubMed ID: 17949555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease.
    Aktas Cetin E; Cosan F; Cefle A; Deniz G
    Mod Rheumatol; 2014 Sep; 24(5):802-7. PubMed ID: 24498963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine profile in Behçet's disease patients. Relationship with disease activity.
    Hamzaoui K; Hamzaoui A; Guemira F; Bessioud M; Hamza M; Ayed K
    Scand J Rheumatol; 2002; 31(4):205-10. PubMed ID: 12369651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of interleukin-27 and effect on production of interferon-γ and interleukin-17 in patients with Behçet's disease.
    Shen H; Xia LP; Lu J
    Scand J Rheumatol; 2013; 42(1):48-51. PubMed ID: 23101722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
    Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
    Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A possible role for interleukin 37 in the pathogenesis of Behcet's disease.
    Ye Z; Wang C; Kijlstra A; Zhou X; Yang P
    Curr Mol Med; 2014 May; 14(4):535-42. PubMed ID: 24730521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IFN-alpha blocks IL-17 production by peripheral blood mononuclear cells in Behcet's disease.
    Liu X; Yang P; Wang C; Li F; Kijlstra A
    Rheumatology (Oxford); 2011 Feb; 50(2):293-8. PubMed ID: 21059671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.